We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$21.7B
1-Year Est. Return
79.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$19.1B
AUM Growth
-$4.04B
(-17%)
Cap. Flow
-$3.24B
Cap. Flow
% of AUM
-16.98%
Top 10 Holdings %
Top 10 Hldgs %
50.33%
Holding
204
New
48
Increased
30
Reduced
30
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA
Electronic Arts
EA
|
+$492M |
| 2 |
Broadcom
AVGO
|
+$292M |
| 3 |
KKR & Co
KKR
|
+$280M |
| 4 |
Roivant Sciences
ROIV
|
+$248M |
| 5 |
Mastercard
MA
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$650M |
| 2 |
CYBR
CyberArk
CYBR
|
+$470M |
| 3 |
Salesforce
CRM
|
+$334M |
| 4 |
Nasdaq
NDAQ
|
+$290M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.53% |
| 2 | Communication Services | 11.31% |
| 3 | Financials | 11.23% |
| 4 | Technology | 10.28% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Littelfuse
LFUS
$11.6B
| $5.09M | 0.03% |
+15,000
| New | +$4.87M |
|
77
Piper Sandler
PIPR
$5.41B
| $5.05M | 0.03% |
+66,000
| New | +$5.42M |
|
78
AAR Corp
AIR
$5.85B
| $5.04M | 0.03% |
+46,000
| New | +$4.95M |
|
79
Rio Tinto
RIO
$156B
| $5.02M | 0.03% |
+53,800
| New | +$4.9M |
|
80
Garrett Motion
GTX
$5.41B
| $5M | 0.03% |
+275,000
| New | +$5.13M |
|
81
Rollins
ROL
$17.4B
| $4.97M | 0.03% |
+93,000
| New | +$5.53M |
|
82
Affirm
AFRM
$26.2B
| $4.95M | 0.03% |
+108,000
| New | +$6.24M |
|
83
Inter&Co
INTR
$2.29B
| $4.89M | 0.03% |
+614,500
| New | +$5.33M |
|
84
Cummins
CMI
$86.9B
| $4.84M | 0.03% |
+9,000
| New | +$5.09M |
|
|
FISV
85
Fiserv Inc
FISV
$28.9B
| $4.8M | 0.03% |
+86,000
| New | +$5.32M |
|
86
Vertiv
VRT
$113B
| $4.76M | 0.03% |
+19,000
| New | +$4.22M |
|
87
Amkor Technology
AMKR
$14.7B
| $4.68M | 0.02% |
104,000
-360,000
| -78% | -$17.2M |
|
|
RNA
88
Atrium Therapeutics
RNA
$220M
| $4.67M | 0.02% |
+349,360
| New | +$4.91M |
|
89
GlobalFoundries
GFS
$30B
| $4.67M | 0.02% |
+105,000
| New | +$4.63M |
|
90
Molina Healthcare
MOH
$11.1B
| $4.67M | 0.02% |
+35,000
| New | +$5.57M |
|
|
IRD
91
Opus Genetics
IRD
$300M
| $4.55M | 0.02% |
+1,000,000
| New | +$3.46M |
|
92
Tenable Holdings
TENB
$4.22B
| $4.48M | 0.02% |
+265,000
| New | +$5.56M |
|
93
Prime Medicine
PRME
$560M
| $4.32M | 0.02% |
1,240,843
| – | – |
|
94
ServiceNow
NOW
$128B
| $4.29M | 0.02% |
+41,000
| New | +$4.82M |
|
|
SMC
95
Summit Midstream
SMC
$482M
| $1.76M | 0.01% |
58,214
| – | – |
|
96
Madrigal Pharmaceuticals
MDGL
$11.7B
| $1.74M | 0.01% |
3,319
| – | – |
|
97
Capricor Therapeutics
CAPR
$385M
| $1.25M | 0.01% |
41,000
| – | – |
|
98
Arrowhead Research
ARWR
$12.2B
| $991K | 0.01% |
15,800
| – | – |
|
|
ANNAW
99
AleAnna Inc Warrant
ANNAW
$9.66M
| $802K | ﹤0.01% |
990,000
| – | – |
|
100
Guardant Health
GH
$21.1B
| $739K | ﹤0.01% |
8,000
-101,000
| -93% | -$10.1M |
|
Similar funds
VARA
PCM
BPA
NAM
ASRS
Farallon Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Farallon Capital Management held 204 positions worth $19.1B, down 17% from $23.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Farallon Capital Management withdrew a net $3.24B in Q1 2026, closing 31 positions and reducing 30 holdings. Its most notable exit was Exact Sciences, an estimated $650M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 41% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Farallon Capital Management opened a new position in Dianthus Therapeutics worth $70.2M.
- Farallon Capital Management's largest Q1 2026 buy was Dianthus Therapeutics: 836,000 shares worth $70.2M.
- Farallon Capital Management added most to Electronic Arts in Q1 2026, an estimated $492M increase.
- Farallon Capital Management's biggest Q1 2026 reduction was Wabtec, cutting an estimated $210M.
- Farallon Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $650M.
- Farallon Capital Management's ten largest holdings make up 50% of its $19.1B portfolio in Q1 2026.
- Farallon Capital Management opened 48 new positions and closed 31 in Q1 2026.
- Farallon Capital Management's portfolio value fell 17% quarter-over-quarter to $19.1B.
Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.